Cite

HARVARD Citation

    Karmali, R. et al. (n.d.). GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA. Hematological oncology. pp. 400-402. [Online]. 
  
Back to record